House Wellness Foods Probiotic Therapeutic Patent Granted
Summary
The USPTO granted Patent US12599638B2 to House Wellness Foods Corporation for a feed and composition comprising Lactobacillus plantarum strain L-137 and a fatty acid. The patent covers compositions for enhancing IL-12 production, immunostimulation, and bacteriostasis. The patent application was filed on September 21, 2021, with 7 claims granted.
What changed
The USPTO issued Patent US12599638B2 to House Wellness Foods Corporation for a feed and therapeutic composition containing Lactobacillus plantarum strain L-137 combined with a fatty acid or salt thereof. The patent covers four embodiments: a feed composition, an IL-12 production enhancer, an immunostimulation composition, and a bacteriostasis composition. The patent grants exclusive rights to the assignee for the claimed lactic acid bacteria and fatty acid formulations.
Competitors in the probiotic, functional food, and nutritional supplement industries should be aware that House Wellness Foods now holds enforceable patent rights covering similar lactic acid bacteria and fatty acid compositions. Companies developing or marketing comparable products may need to evaluate potential licensing requirements or design-around strategies to avoid infringement claims.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Feed and composition comprising lactic acid bacteria and fatty acid
Grant US12599638B2 Kind: B2 Apr 14, 2026
Assignee
HOUSE WELLNESS FOODS CORPORATION
Inventors
Rieko Yoshitake, Tsubasa Nakajima, Yoshitaka Hirose, Mika Yamaguchi
Abstract
A problem to be solved by the present invention is to provide one or more selected from (1) a feed comprising Lactobacillus plantarum strain L-137 or a processed product thereof and a fatty acid or a salt thereof, (2) a composition for enhancing IL-12 production, comprising Lactobacillus plantarum strain L-137 or a processed product thereof and a fatty acid or a salt thereof, (3) a composition for immunostimulation, comprising Lactobacillus plantarum strain L-137 or a processed product thereof and a fatty acid or a salt thereof, and (4) a composition for bacteriostasis, comprising Lactobacillus plantarum strain L-137 or a processed product thereof and a fatty acid or a salt thereof. The problem is solved by providing one or more of the feed or the compositions.
CPC Classifications
A61K 35/747 A61K 31/19 A61K 35/744 A23K 10/16 A23K 20/158 A23K 10/18 A23K 50/75 A61P 31/04 A61P 37/04 C12R 2001/25 A23C 9/1234 A23V 2400/169 A23L 2/52 A23L 33/12 A23L 33/135 A23L 2/38 C12N 1/20 C12N 1/205
Filing Date
2021-09-21
Application No.
18026464
Claims
7
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.